Spinal Muscular Atrophy Program Enters Phase 1b/2a Trial In Patients With SMA
November 19, 2014 at 08:03 AM EST
PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that its joint development program in Spinal Muscular Atrophy (SMA) with Roche and ...